Symbol: |
KAZALD1
|
Description: |
Kazal-type serine peptidase inhibitor domain 1 [Source:HGNC Symbol;Acc:25460]
|
Location: |
Chr10:102821598-102827888[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:230
Gene |
Compound |
Gen_sig |
Exp_pattern |
KAZALD1 |
NSC 665106 |
0.035 |
Up |
KAZALD1 |
Azoxydapsone {1,2-bis-[4-(4'-aminophenylsulfonylphenyl)]- diazine-1-oxide} |
0.02 |
Up |
KAZALD1 |
Olomoucine |
0.013 |
Up |
KAZALD1 |
Bis[1-(4-methylpiperidino)-4-(2-pyridyl)-2,3-diazapenta 1,3-dien-1-thiolato-N',N3,S]nitrato-bismuth(III) |
0.022 |
Down |
KAZALD1 |
NSC 668578 |
0.001 |
Down |
KAZALD1 |
NSC 669308 |
0.001 |
Up |
KAZALD1 |
NSC 669450 |
0.043 |
Up |
KAZALD1 |
trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid |
0.003 |
Down |
KAZALD1 |
Ethanamine, N,N-dimethyl-2-[4-(1,1-dimethylethyl)- 1-[(4-methylphenyl)methyl]cyclohexyloxy]-, (trans)-, (E)-2-butenedioate (fumaric acid) (1:1) |
0.011 |
Down |
KAZALD1 |
NSC 670296 |
0.041 |
Down |
KAZALD1 |
Benzoic acid, 2,4-dichloro-, 6-acetyl-1,2,3,4-tetrahydro- 4-oxo-1,3-diphenyl-2-thioxothieno[2,3-d]pyrimidin-5-yl ester |
0.045 |
Up |
KAZALD1 |
NSC 671689 |
0.021 |
Up |
KAZALD1 |
NSC 671888 |
0.013 |
Down |
KAZALD1 |
NSC 671898 |
0.019 |
Up |
KAZALD1 |
NSC 671945 |
0.042 |
Down |
Expression pattern: Sensitivity / Resistance
Total:16 Current:4
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:12
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:66
Total:5 Current:1
[First] [Prev]  Next Last 
|